{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:05:35Z","timestamp":1781625935716,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["DNA Repair"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.dnarep.2026.103941","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:55:37Z","timestamp":1779429337000},"page":"103941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MLH1 silencing reprograms PI3K\/AKT and JAK\/STAT signaling to enhance 5-Fluorouracil sensitivity in colorectal cancer cells"],"prefix":"10.1016","volume":"163","author":[{"given":"Hali\u0307me","family":"Topal K\u0131z\u0131lo\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adem","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.dnarep.2026.103941_bib1","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.3390\/medicina59091646","article-title":"Colorectal cancer: from risk factors to oncogenesis","volume":"59","author":"Ionescu","year":"2023","journal-title":"Medicina"},{"issue":"11","key":"10.1016\/j.dnarep.2026.103941_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics15112620","article-title":"Colorectal cancer: disease process, current treatment options, and future perspectives","volume":"15","author":"Adebayo","year":"2023","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.dnarep.2026.103941_bib3","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/sj.bjc.6603011","article-title":"FOLFOXIRI vs FOLFIRI as first-line treatment in metastatic colorectal cancer (MCC): A multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)","volume":"94","author":"Vamvakas","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.dnarep.2026.103941_bib4","first-page":"35","article-title":"Investigation of Cytotoxic and Apoptotic Effects of 5-Fluorouracil (5-FU) and C60 Nanoparticle on Breast Cancer (MCF-7) Cell Line","volume":"9","author":"Aybek","year":"2020","journal-title":"Turk. J. Nat. Sci."},{"issue":"2","key":"10.1016\/j.dnarep.2026.103941_bib5","first-page":"149","article-title":"Mutation, DNA damage, repair mechanisms and the relation of cancer. Ankara Eczac\u0131l\u0131","volume":"35","author":"Debele","year":"2006","journal-title":"K. Fak. \u00fcltesi Derg."},{"issue":"4","key":"10.1016\/j.dnarep.2026.103941_bib6","doi-asserted-by":"crossref","first-page":"a012633","DOI":"10.1101\/cshperspect.a012633","article-title":"Postreplicative mismatch repair","volume":"5","author":"Jiricny","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.dnarep.2026.103941_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/cr.2007.115","article-title":"Mechanism and function of DNA mismatch repair","volume":"18","author":"Li","year":"2008","journal-title":"Cell Res."},{"issue":"17","key":"10.1016\/j.dnarep.2026.103941_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/diagnostics15172141","article-title":"Clinical, immunohistochemical, and inflammatory profiles in colorectal cancer: the impact of MMR deficiency","volume":"15","author":"Ionescu","year":"2025","journal-title":"Diagnostics"},{"issue":"2","key":"10.1016\/j.dnarep.2026.103941_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jmoldx.2023.10.005","article-title":"MLH1 promoter hypermethylation in colorectal and endometrial carcinomas from patients with lynch syndrome","volume":"26","author":"Helderman","year":"2024","journal-title":"J. Mol. Diagn."},{"issue":"2","key":"10.1016\/j.dnarep.2026.103941_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.neo.2021.12.003","article-title":"TIGAR mediates cytoprotective nucleophagy to resist 5-Fluorouracil-induced cell death in colorectal cancer","volume":"24","author":"Manzoor","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.dnarep.2026.103941_bib11","article-title":"Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade","volume":"211","author":"Choi","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.dnarep.2026.103941_bib12","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/pharmaceutics13091428","article-title":"siRNA-loaded hydroxyapatite nanoparticles for KRAS gene silencing in anti-pancreatic cancer therapy","volume":"13","author":"Luo","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.dnarep.2026.103941_bib13","doi-asserted-by":"crossref","unstructured":"M. S. Duxbury et al., \u201cSystemic siRNA-Mediated Gene Silencing\u201d, 240, 4,\u00a0265\u2013274, 2004, doi: 10.1097\/01.sla.0000140755.97224.9a.","DOI":"10.1097\/01.sla.0000140755.97224.9a"},{"key":"10.1016\/j.dnarep.2026.103941_bib14","first-page":"1","article-title":"Chemoresistance mechanisms to 5-Fluorouracil and reversal strategies in lung and breast cancer","volume":"15","author":"Zhong","year":"2025","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/j.dnarep.2026.103941_bib15","doi-asserted-by":"crossref","first-page":"12574","DOI":"10.18632\/oncotarget.3728","article-title":"5-Fluorouracil sensitizes colorectal tumor cells towards double stranded DNA breaks by interfering with homologous recombination repair","volume":"6","author":"Srinivas","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.dnarep.2026.103941_bib16","article-title":"Synergistic Antitumor Effect of Dichloroacetate in Combination with 5-Fluorouracil in Colorectal Cancer","volume":"2011","author":"Tong","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"issue":"5","key":"10.1016\/j.dnarep.2026.103941_bib17","first-page":"245","article-title":"Cytotoxicity of 5-fluorouracil-loaded pH-sensitive liposomal nanoparticles in colorectal cancer cell lines","volume":"2","author":"Udofot","year":"2015","journal-title":"Integr. Cancer Sci. Ther."},{"key":"10.1016\/j.dnarep.2026.103941_bib18","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/150845","article-title":"Apoptosis and Molecular Targeting Therapy in Cancer","volume":"2014","author":"Hassan","year":"2014","journal-title":"BioMed. Res. Int."},{"issue":"4","key":"10.1016\/j.dnarep.2026.103941_bib19","first-page":"565","article-title":"Apoptotic Pathways and Targeted Therapies","volume":"27","author":"G\u00f6khan","year":"2020","journal-title":"Med. J. S\u00fcleyman Demirel Univ."},{"key":"10.1016\/j.dnarep.2026.103941_bib20","article-title":"Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer","volume":"21","author":"Ganesh","year":"2013","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.dnarep.2026.103941_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biology10090854","article-title":"Recent Updates on Mechanisms of Resistance to 5-Fluorouracil and Reversal Strategies in Colon Cancer Treatment","volume":"10","author":"Azwar","year":"2021","journal-title":"Biology"},{"issue":"5","key":"10.1016\/j.dnarep.2026.103941_bib22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-Fluorouracil: Mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.dnarep.2026.103941_bib23","first-page":"475","article-title":"Improvement of 5-fluorouracil chemosensitivity in colorectal cancer cells by siRNA-mediated silencing of STAT6 oncogene","volume":"27","author":"Farzam","year":"2024","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"2","key":"10.1016\/j.dnarep.2026.103941_bib24","first-page":"115","article-title":"The role of the PI3K pathway in colorectal cancer","volume":"94","author":"Papadatos-Pastos","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.dnarep.2026.103941_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/CMAR.S169476","article-title":"Deguelin induces apoptosis in colorectal cancer cells by activating the p38 MAPK pathway","volume":"11","author":"Chen","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"6","key":"10.1016\/j.dnarep.2026.103941_bib26","first-page":"1695","article-title":"Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment","volume":"38","author":"Yang","year":"2011","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.dnarep.2026.103941_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0379-4172(06)60027-9","article-title":"MDR1 gene polymorphisms and clinical relevance","volume":"33","author":"Yan-Hong","year":"2006","journal-title":"Acta Genet. Sin."},{"issue":"1","key":"10.1016\/j.dnarep.2026.103941_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ijc.11176","article-title":"Role of hMLH1 Promoter Hypermethylation in Drug Resistance to 5-Fluorouracil in Colorectal Cancer Cell Lines","volume":"106","author":"Arnold","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.dnarep.2026.103941_bib29","doi-asserted-by":"crossref","unstructured":"L. S. Li et al., \u201cREVIEW DNA mismatch repair ( MMR ) -dependent 5-fluorouracil cytotoxicity and the potential for new Abbreviations \u201d:, ss. 679\u2013692, 2009, doi: 10.1111\/j.1476-5381.2009.00423.x.","DOI":"10.1111\/j.1476-5381.2009.00423.x"},{"issue":"11","key":"10.1016\/j.dnarep.2026.103941_bib30","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1002\/ijc.32367","article-title":"Fisetin and 5-fluorouracil: Effective combination for PIK3CA-mutant colorectal cancer","volume":"145","author":"Khan","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.dnarep.2026.103941_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd3010","article-title":"Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application","volume":"9","author":"Jackson","year":"2010","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["DNA Repair"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568786426000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568786426000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:10:20Z","timestamp":1781622620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568786426000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":31,"alternative-id":["S1568786426000200"],"URL":"https:\/\/doi.org\/10.1016\/j.dnarep.2026.103941","relation":{},"ISSN":["1568-7864"],"issn-type":[{"value":"1568-7864","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MLH1 silencing reprograms PI3K\/AKT and JAK\/STAT signaling to enhance 5-Fluorouracil sensitivity in colorectal cancer cells","name":"articletitle","label":"Article Title"},{"value":"DNA Repair","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dnarep.2026.103941","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103941"}}